Gabriela Velazquez-Ramirez
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mesenteric Artery, Superior | 1 | 2016 | 8 | 0.590 |
Why?
|
Celiac Artery | 1 | 2016 | 6 | 0.590 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2016 | 12 | 0.590 |
Why?
|
Angioplasty, Balloon | 1 | 2016 | 30 | 0.580 |
Why?
|
Lower Extremity | 4 | 2018 | 89 | 0.530 |
Why?
|
Vascular Patency | 3 | 2017 | 66 | 0.330 |
Why?
|
Saphenous Vein | 2 | 2017 | 20 | 0.300 |
Why?
|
Vascular Surgical Procedures | 2 | 2019 | 88 | 0.190 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 293 | 0.170 |
Why?
|
Computer-Assisted Instruction | 1 | 2019 | 20 | 0.170 |
Why?
|
Amputation | 1 | 2018 | 35 | 0.170 |
Why?
|
Education, Medical, Undergraduate | 1 | 2019 | 80 | 0.160 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 113 | 0.160 |
Why?
|
Psoas Muscles | 1 | 2017 | 20 | 0.160 |
Why?
|
Hand Strength | 1 | 2017 | 82 | 0.160 |
Why?
|
Marital Status | 1 | 2017 | 21 | 0.150 |
Why?
|
Vascular Diseases | 1 | 2017 | 60 | 0.150 |
Why?
|
Students, Medical | 1 | 2019 | 115 | 0.150 |
Why?
|
Sarcopenia | 1 | 2017 | 53 | 0.150 |
Why?
|
Risk Factors | 4 | 2017 | 3520 | 0.150 |
Why?
|
Heart Diseases | 1 | 2017 | 101 | 0.150 |
Why?
|
Retreatment | 1 | 2016 | 32 | 0.150 |
Why?
|
Constriction, Pathologic | 1 | 2016 | 32 | 0.150 |
Why?
|
Treatment Outcome | 4 | 2017 | 2886 | 0.150 |
Why?
|
Retrospective Studies | 4 | 2017 | 2930 | 0.140 |
Why?
|
Aged | 7 | 2018 | 9256 | 0.140 |
Why?
|
Recurrence | 1 | 2016 | 210 | 0.140 |
Why?
|
Health Status Disparities | 1 | 2016 | 105 | 0.140 |
Why?
|
Stents | 1 | 2016 | 131 | 0.140 |
Why?
|
Internship and Residency | 1 | 2019 | 264 | 0.130 |
Why?
|
Chronic Disease | 1 | 2016 | 359 | 0.130 |
Why?
|
Time Factors | 2 | 2017 | 1874 | 0.130 |
Why?
|
Multivariate Analysis | 4 | 2017 | 631 | 0.120 |
Why?
|
Middle Aged | 6 | 2018 | 10678 | 0.120 |
Why?
|
Male | 8 | 2019 | 16967 | 0.120 |
Why?
|
Female | 8 | 2019 | 17679 | 0.120 |
Why?
|
Cholecystectomy | 1 | 2012 | 16 | 0.110 |
Why?
|
Incidental Findings | 1 | 2012 | 26 | 0.110 |
Why?
|
Aged, 80 and over | 2 | 2017 | 3562 | 0.110 |
Why?
|
Gallbladder Neoplasms | 1 | 2012 | 33 | 0.110 |
Why?
|
Humans | 8 | 2019 | 28304 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 1556 | 0.090 |
Why?
|
Comorbidity | 2 | 2017 | 531 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 774 | 0.060 |
Why?
|
Logistic Models | 2 | 2017 | 727 | 0.060 |
Why?
|
Sex Factors | 2 | 2016 | 619 | 0.050 |
Why?
|
Prognosis | 2 | 2017 | 1342 | 0.050 |
Why?
|
Writing | 1 | 2019 | 10 | 0.040 |
Why?
|
Information Dissemination | 1 | 2019 | 39 | 0.040 |
Why?
|
Muscle Strength Dynamometer | 1 | 2017 | 10 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 2017 | 29 | 0.040 |
Why?
|
Diabetic Angiopathies | 1 | 2018 | 150 | 0.040 |
Why?
|
Frail Elderly | 1 | 2017 | 60 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 152 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2017 | 21 | 0.040 |
Why?
|
Curriculum | 1 | 2019 | 189 | 0.040 |
Why?
|
Cause of Death | 1 | 2017 | 219 | 0.040 |
Why?
|
Linear Models | 1 | 2017 | 421 | 0.040 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2016 | 46 | 0.040 |
Why?
|
Odds Ratio | 1 | 2017 | 457 | 0.040 |
Why?
|
Blood Glucose | 1 | 2018 | 485 | 0.030 |
Why?
|
Registries | 1 | 2017 | 269 | 0.030 |
Why?
|
Adult | 2 | 2019 | 8243 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2017 | 328 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 317 | 0.030 |
Why?
|
Health Status | 1 | 2017 | 360 | 0.030 |
Why?
|
Prevalence | 1 | 2017 | 881 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 706 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 1345 | 0.030 |
Why?
|
North Carolina | 1 | 2017 | 1412 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2018 | 2027 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 858 | 0.030 |
Why?
|
Prospective Studies | 1 | 2017 | 1932 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 2321 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 192 | 0.030 |
Why?
|
Survival Analysis | 1 | 2012 | 424 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2012 | 430 | 0.020 |
Why?
|